The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Antibiotic also called an antibacterial, is a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. A limited number of antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza; drugs which inhibit viruses are termed antiviral drugs or antivirals rather than antibiotics.
The global Antibiotics market was valued at US$ 47 million in 2023 and is anticipated to reach US$ 67 million by 2030, witnessing a CAGR of 5.4% during the forecast period 2024-2030.
More than 15.0% of the deaths, in children below the age of five, are estimated to be due to pneumonia and according to the statistics provided by the WHO about 9.2 million deaths were recorded in 2015. Similar to tuberculosis, the highest prevalence of the disease is identified to be in the South Asian and Sub-Saharan regions. Currently, the required antibiotic treatment is available only to one third of the infected population, thereby increasing the disease burden.
This report aims to provide a comprehensive presentation of the global market for Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibiotics.
Report Scope
The Antibiotics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibiotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Pfizer
- Janssen Pharmaceuticals
- Abbott
- GlaxoSmithKline
- Sanofi
- Novartis
- Bayer
- Bristol Myers Squibb Company
- Eli Lilly and Company
- Astellas Pharma
Segment by Type
- Cephalosporins
- Penicillins
- Fluoroquinolones
- Macrolides
- Carbapenems
- Aminoglycosides
- Sulfonamides
- Others
Segment by Application
- Hospital
- Clinics
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Antibiotics Market Overview
1.1 Product Overview and Scope of Antibiotics
1.2 Antibiotics Segment by Type
1.2.1 Global Antibiotics Market Value Comparison by Type (2024-2030)
1.2.2 Cephalosporins
1.2.3 Penicillins
1.2.4 Fluoroquinolones
1.2.5 Macrolides
1.2.6 Carbapenems
1.2.7 Aminoglycosides
1.2.8 Sulfonamides
1.2.9 Others
1.3 Antibiotics Segment by Application
1.3.1 Global Antibiotics Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Global Antibiotics Market Size Estimates and Forecasts
1.4.1 Global Antibiotics Revenue 2019-2030
1.4.2 Global Antibiotics Sales 2019-2030
1.4.3 Global Antibiotics Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antibiotics Market Competition by Manufacturers
2.1 Global Antibiotics Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antibiotics Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antibiotics Average Price by Manufacturers (2019-2024)
2.4 Global Antibiotics Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antibiotics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antibiotics, Product Type & Application
2.7 Antibiotics Market Competitive Situation and Trends
2.7.1 Antibiotics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antibiotics Players Market Share by Revenue
2.7.3 Global Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antibiotics Retrospective Market Scenario by Region
3.1 Global Antibiotics Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antibiotics Global Antibiotics Sales by Region: 2019-2030
3.2.1 Global Antibiotics Sales by Region: 2019-2024
3.2.2 Global Antibiotics Sales by Region: 2025-2030
3.3 Global Antibiotics Global Antibiotics Revenue by Region: 2019-2030
3.3.1 Global Antibiotics Revenue by Region: 2019-2024
3.3.2 Global Antibiotics Revenue by Region: 2025-2030
3.4 North America Antibiotics Market Facts & Figures by Country
3.4.1 North America Antibiotics Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antibiotics Sales by Country (2019-2030)
3.4.3 North America Antibiotics Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antibiotics Market Facts & Figures by Country
3.5.1 Europe Antibiotics Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antibiotics Sales by Country (2019-2030)
3.5.3 Europe Antibiotics Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antibiotics Market Facts & Figures by Country
3.6.1 Asia Pacific Antibiotics Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antibiotics Sales by Country (2019-2030)
3.6.3 Asia Pacific Antibiotics Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antibiotics Market Facts & Figures by Country
3.7.1 Latin America Antibiotics Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antibiotics Sales by Country (2019-2030)
3.7.3 Latin America Antibiotics Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antibiotics Market Facts & Figures by Country
3.8.1 Middle East and Africa Antibiotics Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antibiotics Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antibiotics Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Antibiotics Sales by Type (2019-2030)
4.1.1 Global Antibiotics Sales by Type (2019-2024)
4.1.2 Global Antibiotics Sales by Type (2025-2030)
4.1.3 Global Antibiotics Sales Market Share by Type (2019-2030)
4.2 Global Antibiotics Revenue by Type (2019-2030)
4.2.1 Global Antibiotics Revenue by Type (2019-2024)
4.2.2 Global Antibiotics Revenue by Type (2025-2030)
4.2.3 Global Antibiotics Revenue Market Share by Type (2019-2030)
4.3 Global Antibiotics Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antibiotics Sales by Application (2019-2030)
5.1.1 Global Antibiotics Sales by Application (2019-2024)
5.1.2 Global Antibiotics Sales by Application (2025-2030)
5.1.3 Global Antibiotics Sales Market Share by Application (2019-2030)
5.2 Global Antibiotics Revenue by Application (2019-2030)
5.2.1 Global Antibiotics Revenue by Application (2019-2024)
5.2.2 Global Antibiotics Revenue by Application (2025-2030)
5.2.3 Global Antibiotics Revenue Market Share by Application (2019-2030)
5.3 Global Antibiotics Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Antibiotics Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Janssen Pharmaceuticals
6.2.1 Janssen Pharmaceuticals Corporation Information
6.2.2 Janssen Pharmaceuticals Description and Business Overview
6.2.3 Janssen Pharmaceuticals Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Janssen Pharmaceuticals Antibiotics Product Portfolio
6.2.5 Janssen Pharmaceuticals Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Antibiotics Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Antibiotics Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi Antibiotics Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Novartis Antibiotics Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bayer Antibiotics Product Portfolio
6.7.5 Bayer Recent Developments/Updates
6.8 Bristol Myers Squibb Company
6.8.1 Bristol Myers Squibb Company Corporation Information
6.8.2 Bristol Myers Squibb Company Description and Business Overview
6.8.3 Bristol Myers Squibb Company Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bristol Myers Squibb Company Antibiotics Product Portfolio
6.8.5 Bristol Myers Squibb Company Recent Developments/Updates
6.9 Eli Lilly and Company
6.9.1 Eli Lilly and Company Corporation Information
6.9.2 Eli Lilly and Company Description and Business Overview
6.9.3 Eli Lilly and Company Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Eli Lilly and Company Antibiotics Product Portfolio
6.9.5 Eli Lilly and Company Recent Developments/Updates
6.10 Astellas Pharma
6.10.1 Astellas Pharma Corporation Information
6.10.2 Astellas Pharma Description and Business Overview
6.10.3 Astellas Pharma Antibiotics Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Astellas Pharma Antibiotics Product Portfolio
6.10.5 Astellas Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antibiotics Industry Chain Analysis
7.2 Antibiotics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antibiotics Production Mode & Process
7.4 Antibiotics Sales and Marketing
7.4.1 Antibiotics Sales Channels
7.4.2 Antibiotics Distributors
7.5 Antibiotics Customers
8 Antibiotics Market Dynamics
8.1 Antibiotics Industry Trends
8.2 Antibiotics Market Drivers
8.3 Antibiotics Market Challenges
8.4 Antibiotics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
